Literature DB >> 1832937

Anti-GPIIb/IIIa (CD41) monoclonal antibody-induced platelet activation requires Fc receptor-dependent cell-cell interaction.

G P Anderson1, J G van de Winkel, C L Anderson.   

Abstract

We studied platelet activation by UR1, a murine IgG1 anti-CD41 mAb. Like thrombin and crosslinked anti-Fc gamma RII mAb IV3, UR1 initiates prompt aggregation and Ca2+ mobilization. UR1 F(ab')2 fragments failed to activate, yet inhibited UR1 IgG-mediated activation. UR1-induced activation was blocked by anti-Fc gamma RII mAb. High viscosity (15% dextran or Ficoll), which impedes cell-cell interaction, inhibited activation by UR1. Cell-cell interaction was confirmed by cell-mixing studies. UR1 binding to platelets of one pool was blocked with UR1 F(ab')2 allowing UR1 binding only to Fc gamma RII. IV3 Fab fragments blocked ligand binding to Fc gamma RII on platelets of a second pool; thus, UR1 could bind only its epitope. UR1 initiated an immediate [Ca2+]i increase in the intermixed pools at low ionic strength. These studies indicate that UR1 IgG binds CD41 on one platelet to form immune complexes which then crosslink and stimulate Fc gamma RII on nearby platelets. Two other anti-CD41 mAb, 6C9 and C17, and two anti-CD9 mAb, AG1 and mAb7, activated platelets in a UR1-like manner. We propose that platelet Fc gamma RII crosslinking that follows the interaction of IgG-opsonized platelets may be a common mechanism by which anti-platelet antibodies activate platelets.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1832937     DOI: 10.1111/j.1365-2141.1991.tb08010.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Mechanisms of platelet activation by a stimulatory antibody: cross-linking of a novel platelet receptor for monoclonal antibody F11 with the Fc gamma RII receptor.

Authors:  U P Naik; Y H Ehrlich; E Kornecki
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

2.  Heparin-induced thrombocytopenia with associated thrombosis in children after the Fontan operation: report of two cases.

Authors:  Rosalia Porcelli; Bonnie C Moskowitz; Frank Cetta; Lynn C Graham; John E Godwin; Benjamin W Eidem; M Margaret Prechel; Jeanine M Walenga
Journal:  Tex Heart Inst J       Date:  2003

3.  Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets.

Authors:  Brian Boylan; Cunji Gao; Vipul Rathore; Joan C Gill; Debra K Newman; Peter J Newman
Journal:  Blood       Date:  2008-07-18       Impact factor: 22.113

4.  Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.

Authors:  Christian Lood; Helena Tydén; Birgitta Gullstrand; Gunnar Sturfelt; Andreas Jönsen; Lennart Truedsson; Anders A Bengtsson
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

5.  GPIbα is the driving force of hepatic thrombopoietin generation.

Authors:  Danielle Karakas; Miao Xu; Heyu Ni
Journal:  Res Pract Thromb Haemost       Date:  2021-05-03

6.  Apoptosis signal-regulating kinase 1 regulates immune-mediated thrombocytopenia, thrombosis, and systemic shock.

Authors:  Pravin Patel; Noor F Shaik; Yuhang Zhou; Kalyan Golla; Steven E McKenzie; Ulhas P Naik
Journal:  J Thromb Haemost       Date:  2020-09-09       Impact factor: 5.824

7.  Platelets Aggregate With Neutrophils and Promote Skin Pathology in Psoriasis.

Authors:  Franziska Herster; Zsofia Bittner; Marius Cosmin Codrea; Nathan K Archer; Martin Heister; Markus W Löffler; Simon Heumos; Joanna Wegner; Ramona Businger; Michael Schindler; David Stegner; Knut Schäkel; Stephan Grabbe; Kamran Ghoreschi; Lloyd S Miller; Alexander N R Weber
Journal:  Front Immunol       Date:  2019-08-16       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.